von Moltke Lisa
- SEC CIK
- 0001808592
No open-market purchases or sales filed in the past year.
Current role at each company
- ZBIO Zenas BioPharma, Inc.See Remarksas of Jun 17, 2026
- MCRB Seres Therapeutics, Inc.See Remarksas of Feb 19, 2025
- TVRD Tvardi Therapeutics, Inc.Directoras of Jun 6, 2024
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists von Moltke Lisa as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
MCRB Seres Therapeutics, Inc.
See Remarks7 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Feb 19, 2025 (view filing) | Feb 18 | 1 day | von Moltke LisaSee Remarks | SSale | −4.42K | $0.81 | −$3.58K | −10.0%39.9K after | 10b5-1 |
| Nov 19, 2024 (view filing) | Nov 18 | 1 day | von Moltke LisaSee Remarks | SSale | −977 | $0.54 | −$527.58 | −2.9%32.4K after | 10b5-1 |
| Oct 29, 2024 (view filing) | Oct 28 | 1 day | von Moltke LisaSee Remarks | SSale | −4.33K | $0.69 | −$2.99K | −12.5%30.4K after | 10b5-1 |
| Aug 19, 2024 (view filing) | Aug 16 | 3 days | von Moltke LisaSee Remarks | SSale | −973 | $0.84 | −$817.32 | −4.4%21.0K after | 10b5-1 |
| May 17, 2024 (view filing) | May 15 | 2 days | von Moltke LisaSee Remarks | SSale | −939 | $0.94 | −$882.66 | −4.7%19.0K after | 10b5-1 |
| Feb 16, 2024 (view filing) | Feb 16 | Same day | von Moltke LisaSee Remarks | SSale | −4.40K | $1.08 | −$4.75K | −20.6%17.0K after | 10b5-1 |
| Oct 31, 2023 (view filing) | Oct 30 | 1 day | von Moltke LisaSee Remarks | SSale | −4.23K | $1.35 | −$5.71K | −30.8%9.51K after | 10b5-1 |